These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2. Grailer A; Nichols J; Hullett D; Sollinger HW; Burlingham WJ Transplant Proc; 1991 Feb; 23(1 Pt 1):314-5. PubMed ID: 1990540 [No Abstract] [Full Text] [Related]
28. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents. Hullett DA; Sollinger HW Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943 [TBL] [Abstract][Full Text] [Related]
29. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428 [No Abstract] [Full Text] [Related]
30. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Zeevi A; Yao GZ; Venkataramanan R; Duquesnoy RJ; Todo S; Fung JJ; Starzl TE Transplant Proc; 1993 Feb; 25(1 Pt 1):781-3. PubMed ID: 7679843 [No Abstract] [Full Text] [Related]
31. Combined standard and novel immunosuppressive substances affect B-lymphocyte function. Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone. Haneda M; Owaki M; Kuzuya T; Iwasaki K; Miwa Y; Kobayashi T Transplantation; 2014 Feb; 97(4):405-12. PubMed ID: 24445924 [TBL] [Abstract][Full Text] [Related]
33. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells. Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207 [TBL] [Abstract][Full Text] [Related]
35. Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms. de Lathouder S; Gerards AH; de Groot ER; Valkhof M; Aarden LA Eur Cytokine Netw; 2002; 13(3):317-23. PubMed ID: 12231475 [TBL] [Abstract][Full Text] [Related]
36. The problem with generic immunosuppressants. Filler G; Kobrzyński M Pediatr Transplant; 2014 Sep; 18(6):551-3. PubMed ID: 25123955 [No Abstract] [Full Text] [Related]
37. Mechanisms of action of mycophenolic acid. Allison AC; Kowalski WJ; Muller CD; Eugui EM Ann N Y Acad Sci; 1993 Nov; 696():63-87. PubMed ID: 7906496 [No Abstract] [Full Text] [Related]
38. Immunosuppressive and other anti-rheumatic activities of mycophenolate mofetil. Allison AC; Eugui EM Agents Actions Suppl; 1993; 44():165-88. PubMed ID: 8372727 [No Abstract] [Full Text] [Related]
39. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation. Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666 [TBL] [Abstract][Full Text] [Related]